Predictive value of flow cytometry for metastatic potential in breast cancer

American Surgeon

Volumn 65, Issue 5, 1999, Pages 434-438

  Schmidt, Hank ^a   Wei, John P ^a   Yeh, Karen A ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER SIZE; CELL CYCLE S PHASE; DNA CONTENT; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS; PLOIDY;

AXILLA; BREAST NEOPLASMS; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; PLOIDIES; PREDICTIVE VALUE OF TESTS;

EID: 0032948908     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. American Joint Committee on Cancer. Manual for Staging of Cancer, 4th Ed. Philadelphia: JB Lippincott Company, 1992, pp 149-53.
2. Clark G. Prognostic and predictive factors. In: Harris J, ed. Diseases of the Breast. Philadelphia: Lippincott-Raven, 1996.
3. Clark JS, George WD, Campbell AM. Dual color flow cytometry of p53 and c-erbB-2 expression related to DNA aneuploidy in primary and metastatic breast cancer. Cancer Lett 1992;66:193-200.
4. Friedman NS, Freedman MD. Correlation of DNA flow cytometry and hormone receptors with axillary lymph node status in patients with carcinoma of the breast. Md Med J 1994;43:963-5.
5. Visscher DW, Zarbo RJ, Jacobsen G, et al. Multiparametric deoxyribonucleic acid and cell cycle analysis of breast carcinomas by flow cytometry: Clinicopathologic correlations. Lab Invest 1990;62:370-8.
6. O'Reilly SM, Camplejohn RS, Barnes DM, et al. DNA index, S-phase fraction, histological grade and prognosis in breast cancer. Br J Cancer 1990;61:671-4.
7. Toikkanen S, Joensuu H, Klemi P. The prognostic significance of nuclear DNA content in invasive breast cancer: A study with long-term follow-up. Br J Cancer 1989;60:693-700.
8. Dressler LG, Seamer LC, Owens MA, et al. DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens. Cancer 1988;61:420.
9. Dressler LG, Seamer L, Owens MA, et al. Evaluation of a modeling system for S-phase estimation in breast cancer by flow cytometry. Cancer Res 1987;47:5294.
10. Chadha M, Chabon AB, Friedmann P, Vikram B. Predictors of axillary lymph node metastases in patients with T1 breast cancer: A multivariate analysis. Cancer 1994;73:350-3.
11. Ravdin PM, De Laurentiis M, Vendely T, Clark GM. Prediction of axillary lymph node status in breast cancer patients by use of prognostic indicators. J Natl Cancer Inst 1994; 86:1771-5.
12. Hedley, DW. DNA flow cytometry and breast cancer. DNA Cytometry Consensus Conference in Breast Cancer Research and Treatment 1993;28:31-53.
13. Hedley DW, Clark GM, Cornelisse CJ, et al. Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast. DNA Cytometry Consensus Conference in Breast Cancer Research and Treatment 1993;28:55-9.
14. Martinez JE, Beck JR, Allsbrook WC Jr, Pantazis CG. Flow cytometric DNA analysis. Clin Lab Sci 1990;3.
15. Batsakis JG, Sneige N, El-Nagar AK. Flow cytometric (DNA content and S-phase fraction) analysis of breast cancer. Cancer 1992;71(Suppl):2151-3.